IFNG and neoplasm: A heterogeneous expression pattern of IFN-γ and IL-17 was found in tumors, which correlated with the expression of KRAS, MUC4, mesothelin or tumor-associated antigens with CD3+ T cells producing IFN-γ mainly found in tertiary lymphoid structures (TLS).